NEUROONE MEDICAL TECHNOLOGIES Corp
NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-06-0820:32 ET | 8-K | 5.07 Shareholder vote results | 0001213900-21-031466 |
| 2021-05-2521:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-029116 |
| 2021-05-1420:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026426 |
| 2021-05-0612:37 ET | DEF 14A | Proxy statementPeriod 2021-06-02 | 0001213900-21-024789 |
| 2021-03-3113:13 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-018989 |
| 2021-03-0501:30 ET | S-1/A | Registration statement, amended | 0001213900-21-013520 |
| 2021-02-2313:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-010996 |
| 2021-02-1621:49 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001213900-21-009675 |
| 2021-02-1221:25 ET | 10-K/A | Annual report, amendedPeriod 2020-09-30 | 0001213900-21-008993 |
| 2021-02-1021:01 ET | S-1 | Registration statement | 0001213900-21-008033 |
| 2021-01-2821:17 ET | 10-K/A | Annual report, amendedPeriod 2020-09-30 | 0001213900-21-004908 |
| 2021-01-1513:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-002402 |
| 2021-01-0713:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-21-000810 |
| 2020-12-0900:36 ET | 10-K | Annual reportPeriod 2020-09-30 | 0001213900-20-041661 |
| 2020-10-0612:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-030207 |
| 2020-09-0320:17 ET | 8-K | 3.02 Unregistered sale of equity | 0001213900-20-025222 |
| 2020-08-2722:59 ET | S-1/A | Registration statement, amended | 0001213900-20-023907 |
| 2020-08-1320:27 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001213900-20-021898 |
| 2020-08-1200:12 ET | S-1 | Registration statement | 0001213900-20-021492 |
| 2020-08-0320:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-019896 |
| 2020-07-2812:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-018777 |
| 2020-07-2212:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-018233 |
| 2020-07-0218:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-016538 |
| 2020-06-0420:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-20-014109 |
| 2020-05-1420:20 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001213900-20-012278 |
| 2020-05-1220:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-011839 |
| 2020-05-0120:43 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-010775 |
| 2020-05-0113:26 ET | DEF 14A | Proxy statementPeriod 2020-06-02 | 0001213900-20-010710 |
| 2020-04-3021:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-010673 |
| 2020-04-0621:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-20-008662 |
| 2020-02-2413:50 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-20-004573 |
| 2020-02-1420:52 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0001213900-20-003930 |
| 2020-01-2821:55 ET | 10-K/A | Annual report, amendedPeriod 2019-09-30 | 0001213900-20-002019 |
| 2020-01-2421:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-20-001745 |
| 2019-12-3121:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-19-027296 |
| 2019-12-2022:17 ET | 10-K | Annual reportPeriod 2019-09-30 | 0001213900-19-026720 |
| 2019-12-1121:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-19-025880 |
| 2019-12-0421:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-19-025318 |
| 2019-12-0214:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-025070 |
| 2019-11-0721:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-19-022367 |
| 2019-10-2920:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-19-021393 |
| 2019-10-2922:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-19-057011 |
| 2019-10-2520:49 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-19-021161 |
| 2019-10-1120:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-19-020209 |
| 2019-09-2313:42 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-19-018619 |
| 2019-08-1420:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-19-015854 |
| 2019-08-1420:06 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001213900-19-015795 |
| 2019-08-0520:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-19-014618 |
| 2019-07-1520:22 ET | S-1 | Registration statement | 0001213900-19-012721 |
| 2019-07-0520:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-19-012136 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.